TABLE 1.
Baseline characteristics (n = 143).
| Age, years, mean (SD) | 68.3 (7.3) |
|---|---|
| Race | |
| African American | 12 (8%) |
| Asian | 4 (5%) |
| Caucasian | 113 (79%) |
| Other a | 13 (8%) |
| Prostate volume, cc | |
| ≤40 | 69 (48%) |
| 41–55 | 41 (29%) |
| >55 | 33 (23%) |
| ROI characteristics | |
| PI‐RADS v2 | |
| Negative | 3 (2%) |
| 3 | 16 (12%) |
| 4 | 58 (45%) |
| 5 | 53 (41%) |
| Diameter (mm), median (IQR) | 14 (11, 17) |
| Location | |
| Anterior | 94 (66%) |
| Posterior | 49 (34%) |
| Laterality | |
| Left | 82 (57%) |
| Right | 60 (42%) |
| Unknown | 1 (1%) |
| Grade group | |
| 1 (MCCL ≥ 6 mm) | 5 (4%) |
| 2 | 92 (64%) |
| 3 | 36 (25%) |
| 4 | 10 (7%) |
| MCCL b (mm), median (IQR) | 7 (5, 9) |
| % Pattern 4, median (IQR) c | 20 (10, 30) |
a
Other race includes Latin American and other.
b
MCCL = maximum cancer core length.
c
Among the 92 patients with GG2.